Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY11.20 CNY
Change Today +0.92 / 8.95%
Volume 27.3M
000153 On Other Exchanges
As of 3:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

anhui fengyuan pharmaceuti-a (000153) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/12/15 - CNY19.99
52 Week Low
07/7/15 - CNY8.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ANHUI FENGYUAN PHARMACEUTI-A (000153)

Related News

No related news articles were found.

anhui fengyuan pharmaceuti-a (000153) Related Businessweek News

No Related Businessweek News Found

anhui fengyuan pharmaceuti-a (000153) Details

Anhui Fengyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine. The company provides APIs, including antipyretic-analgesic and sedative-hypnotic drugs, as well as cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs. It also offers general medicine for vitamin and mineral deficiency, such as tablets and injections. In addition, the company provides chloramphenicol tablets, chloramphenicol capsules, ciprofloxacin hydrochloride tablets, ofloxacin capsules, compound sulfamethoxazole tablets, compound sulfadiazine tablets, erythromycin enteric-coated tablets, erythromycin ethylsuccinate granules, metronidazole tablets, gentamycin sulfate injection, gentamycin sulfate tablets, meleumycin tablets, tetracycline tablets, oxytetracycline tablets, acetylspiramycin tablets, cefotaxime sodium for injection, cefradine capsules, cefalexin capsules, micronomicin sulfate injection, amikacin sulfate injection, etc. for resisting the microorganisms. Further, it offers compound quinine injections for resisting parasitic diseases; ribavirin injection, an antiviral medicine; and oxytocin injection, a uterine contractive medicine. Additionally, the company engages in the retail and wholesale of drugs. Anhui Fengyuan Pharmaceutical Co., Ltd. sells its products through sales networks in Southeast Asia, Africa, and South America. The company is headquartered in Hefei, China.

anhui fengyuan pharmaceuti-a (000153) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

anhui fengyuan pharmaceuti-a (000153) Key Developments

Anhui Fengyuan Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 29, 2015

Anhui Fengyuan Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 29, 2015

Anhui Fengyuan Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2015

Anhui Fengyuan Pharmaceutical Co., Ltd., Annual General Meeting, Apr 22, 2015., at 14:00 China Standard Time. Agenda: To consider the 2014 annual report and its summary; to considers the 2014 work report of the board of directors; to considers the 2014 work report of the supervisory committee; to considers the 2014 financial resolution report; to considers the 2014 profit distribution plan; to considers the Re-appointment of audit firm and its audit fee; to considers the 2015 application for loan comprehensive credit line to banks; and to considers the Change of supervisors.

Anhui Fengyuan Pharmaceutical Co., Ltd. to Report Fiscal Year 2014 Results on Mar 19, 2015

Anhui Fengyuan Pharmaceutical Co., Ltd. announced that they will report fiscal year 2014 results on Mar 19, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000153:CH CNY11.20 CNY +0.92

000153 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000153.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000153 Industry Range
Price/Earnings 78.9x
Price/Sales 2.0x
Price/Book 3.0x
Price/Cash Flow 79.0x
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANHUI FENGYUAN PHARMACEUTI-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at